Cyanotech (NASDAQ:CYAN) released its quarterly earnings data on Tuesday. The biotechnology company reported $0.19 earnings per share for the quarter, Bloomberg Earnings reports. The firm had revenue of $9.15 million during the quarter. Cyanotech had a return on equity of 10.51% and a net margin of 5.44%.
Shares of Cyanotech (CYAN) opened at $5.31 on Thursday. Cyanotech has a 52 week low of $3.25 and a 52 week high of $5.78. The company has a market capitalization of $30.20, a price-to-earnings ratio of 16.93 and a beta of 0.99. The company has a quick ratio of 0.72, a current ratio of 2.36 and a debt-to-equity ratio of 0.33.
Separately, ValuEngine lowered Cyanotech from a “hold” rating to a “sell” rating in a research note on Friday, November 10th.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.com-unik.info/2018/02/08/cyanotech-cyan-posts-earnings-results.html.
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.